Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey

被引:133
作者
Andrews, EB
Eaton, SC
Hollis, KA
Hopkins, JS
Ameen, V
Hamm, LR
Cook, SF
Tennis, P
Mangel, AW
机构
[1] RTI Hlth Solut, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
关键词
D O I
10.1111/j.1365-2036.2005.02671.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Irritable bowel syndrome is a common gastrointestinal disorder, and its prevalence and demographics have been evaluated by different methodologies with varying results. Aim: To evaluate irritable bowel syndrome demographic and prevalence characteristics utilizing a web-enabled panel. Methods: From an existing 150 000-member panel, 31 829 individuals were randomly selected and sent screening questionnaires to evaluate irritable bowel syndrome symptoms. Individuals who agreed to participate and completed the screening questionnaire received a second questionnaire related to a diagnosis of irritable bowel syndrome, a more detailed symptom description, and additional burden of illness data. Results: Irritable bowel syndrome prevalence was 7%. Prevalence was higher in women vs. men, unmarried individuals vs. married individuals and unemployed individuals vs. employed individuals. Of those completing the second questionnaire, 51% had seen their physicians for irritable bowel syndrome symptoms in the past year and most had an episode within the past 3 months. During the past year, approximately half of the participants had used a prescription medication, and over 90% had used an over-the-counter medication for irritable bowel syndrome. Participants with irritable bowel syndrome demonstrated quality-of-life reductions relative to norms of the United States population. Conclusions: Web-enabled data collection represents a novel tool for rapidly surveying a large population of individuals with irritable bowel syndrome symptoms.
引用
收藏
页码:935 / 942
页数:8
相关论文
共 34 条
[1]   Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial [J].
Camilleri, M ;
Northcutt, AR ;
Kong, S ;
Dukes, GE ;
McSorley, D ;
Mangel, AW .
LANCET, 2000, 355 (9209) :1035-1040
[2]  
Camilleri M, 1999, ALIMENT PHARM THERAP, V13, P1149
[3]   Web surveys - A review of issues and approaches [J].
Couper, MP .
PUBLIC OPINION QUARTERLY, 2000, 64 (04) :464-494
[4]   Functional bowel disorders and irritable bowel syndrome in Europe [J].
Delvaux, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 :75-79
[5]   UNITED-STATES HOUSEHOLDER SURVEY OF FUNCTIONAL GASTROINTESTINAL DISORDERS - PREVALENCE, SOCIODEMOGRAPHY, AND HEALTH IMPACT [J].
DROSSMAN, DA ;
LI, ZM ;
ANDRUZZI, E ;
TEMPLE, RD ;
TALLEY, NJ ;
THOMPSON, WG ;
WHITEHEAD, WE ;
JANSSENS, J ;
FUNCHJENSEN, P ;
CORAZZIARI, E ;
RICHTER, JE ;
KOCH, GG .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (09) :1569-1580
[6]  
Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095
[7]   IRRITABLE-BOWEL-SYNDROME IN OFFICE-BASED PRACTICE IN THE UNITED-STATES [J].
EVERHART, JE ;
RENAULT, PF .
GASTROENTEROLOGY, 1991, 100 (04) :998-1005
[8]   The impact of irritable bowel syndrome on health-related quality of life [J].
Gralnek, IM ;
Hays, RD ;
Kilbourne, A ;
Naliboff, B ;
Mayer, EA .
GASTROENTEROLOGY, 2000, 119 (03) :654-660
[9]   Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom [J].
Hahn, BA ;
Yan, SK ;
Strassels, S .
DIGESTION, 1999, 60 (01) :77-81
[10]   Abdominal and pelvic surgery in patients with irritable bowel syndrome [J].
Hasler, WL ;
Schoenfeld, P .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) :997-1005